|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2005-3-22
|
|
pubmed:abstractText |
Increased levels of tumor necrosis factor-alpha (TNF-alpha) correlate with poor prognoses in chronic heart failure (CHF). This study demonstrated that noradrenaline and isoproterenol inhibit TNF-alpha production in patients with CHF in ex vivo whole blood in a dose-dependent fashion. The beta-blocker bisoprolol abolishes this effect.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0002-9149
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
95
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
885-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15781025-Adrenergic beta-Antagonists,
pubmed-meshheading:15781025-Adult,
pubmed-meshheading:15781025-Bisoprolol,
pubmed-meshheading:15781025-Cardiovascular Agents,
pubmed-meshheading:15781025-Female,
pubmed-meshheading:15781025-Heart Failure,
pubmed-meshheading:15781025-Humans,
pubmed-meshheading:15781025-Isoproterenol,
pubmed-meshheading:15781025-Lipopolysaccharides,
pubmed-meshheading:15781025-Male,
pubmed-meshheading:15781025-Norepinephrine,
pubmed-meshheading:15781025-Receptors, Adrenergic, beta,
pubmed-meshheading:15781025-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors.
|
|
pubmed:affiliation |
Department of Clinical Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom. stephan.von.haehling@web.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
